Bartoló-Ibars, A.; Uribe-Herranz, M.; Muñoz-Sánchez, G.; Arnaldos-Pérez, C.; Ortiz-Maldonado, V.; Urbano-Ispizua, Á.; Pascal, M.; Juan, M.
CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies? Cancers 2021, 13, 4664.
https://doi.org/10.3390/cancers13184664
AMA Style
Bartoló-Ibars A, Uribe-Herranz M, Muñoz-Sánchez G, Arnaldos-Pérez C, Ortiz-Maldonado V, Urbano-Ispizua Á, Pascal M, Juan M.
CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies? Cancers. 2021; 13(18):4664.
https://doi.org/10.3390/cancers13184664
Chicago/Turabian Style
Bartoló-Ibars, Ariadna, Mireia Uribe-Herranz, Guillermo Muñoz-Sánchez, Cristina Arnaldos-Pérez, Valentín Ortiz-Maldonado, Álvaro Urbano-Ispizua, Mariona Pascal, and Manel Juan.
2021. "CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?" Cancers 13, no. 18: 4664.
https://doi.org/10.3390/cancers13184664
APA Style
Bartoló-Ibars, A., Uribe-Herranz, M., Muñoz-Sánchez, G., Arnaldos-Pérez, C., Ortiz-Maldonado, V., Urbano-Ispizua, Á., Pascal, M., & Juan, M.
(2021). CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies? Cancers, 13(18), 4664.
https://doi.org/10.3390/cancers13184664